HCG Funds Management

HCG concentrates on private credit and special situations in the US lower middle market. The firm invests across the capital structure, using direct loans, structured equity, and preferred equity to address capital gaps at smaller companies. Its opportunistic posture targets situations where complexity or limited access to traditional financing creates favorable entry terms.

The firm does not publicly disclose its leadership team or investment committee. No principals are identified in public filings, media coverage, or online professional profiles. This operational opacity is deliberate and limits external visibility into the decision-making structure.

HCG's fundraising structure is not publicly known. The absence of a marketing footprint, website, and regulatory filings that would normally accompany broad institutional fundraising suggests the firm likely operates with permanent or closely held capital rather than actively soliciting external limited partners.

Specific check sizes are not disclosed. Based on the lower middle market focus, investment amounts likely range from single-digit millions to approximately $25 million per transaction, consistent with managers targeting companies where traditional private credit funds are less active.

HCG has not published negative sector screens or an exclusion list. Given its special situations mandate, the firm likely evaluates opportunities across most industries and avoids only those sectors where regulatory or reputational risk outweighs the return potential, though this remains inferential.